Jonathan N. Thon

universityaffairs.ca/opinion/the-bl… via @ua_magazine

2023 Reflections and Outlook for 2024 strm.bio/blog/2023-refl…

Tactically Engaging Your Scientific Advisory Board (SAB), by @bios_community open.substack.com/pub/bioscommun…

STRM.BIO CEO Jonathan Thon, Ph.D. to Deliver the 2023 R. D. Zeigler Innovation Research Lecture Sponsored by the V... prn.to/3tABxZD

Tactically Engaging Your Scientific Advisory Board (SAB), by @bios_community open.substack.com/pub/bioscommun…

STRM.BIO Presents Preclinical Data on a Novel Bone Marrow/HSPC-Targeted, Megakaryocyte-Derived Extracellular Vesicle Delivery Platform for In Vivo Gene Therapy at the Cell & Gene Meeting on the Mesa | BioSpace biospace.com/article/releas… #jobs

STRM.BIO Receives Extension of Grant to Advance In Vivo Gene Therapy Delivery Platform prn.to/3ZCYwiI

STRM.BIO to Present at 2023 Cell & Gene Meeting on the Mesa prn.to/456UhNf

Why Repeatability of Dosing Matters for Gene Delivery cellandgene.com/doc/why-repeat…

Inspiring the Next Generation of Entrepreneurs strm.bio/blog/inspiring…

STRM.BIO Appoints Independent Director Minnie Mildwoff, to its Board of Directors prn.to/3Y6cDMv

Cellular shuttle systems, by @ElliotHershberg open.substack.com/pub/centuryofb…

A mental-health crisis is gripping science — toxic research culture is to blame nature.com/articles/d4158…

Financing in a Challenging Environment strm.bio/blog/financing…

Confronting Challenges in Developing Cell and Gene Therapies insideprecisionmedicine.com/topics/precisi… via @clinicalomics

STRM.BIO Appoints Independent Director Dawn Bell, PharmD, to its Board prn.to/455MW1U

Opinion #3: What Makes a Great Scientific Advisory Board (SAB)? by @bios_community link.medium.com/GQDd26beOyb

A Better Way Series, Part V: Microvesicles Allow Repeat Dosing strm.bio/blog/a-better-…

A Better Way Series, Part IV: Microvesicles are a Safer Delivery Platform strm.bio/blog/part-iv-m…